Subbu Nambi
Stock Analyst at Guggenheim
(2.17)
# 2,769
Out of 4,906 analysts
41
Total ratings
42.42%
Success rate
-1.5%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAI Caris Life Sciences | Initiates: Buy | $32 | $28.29 | +13.11% | 1 | Jul 14, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $88 → $115 | $78.35 | +46.79% | 1 | Jun 30, 2025 | |
| TEM Tempus AI | Maintains: Buy | $65 → $75 | $58.01 | +29.29% | 3 | Jun 30, 2025 | |
| NEOG Neogen | Maintains: Buy | $13 → $10 | $4.78 | +109.21% | 3 | Jun 30, 2025 | |
| ILMN Illumina | Maintains: Buy | $122 → $114 | $94.80 | +20.26% | 3 | May 9, 2025 | |
| TWST Twist Bioscience | Reiterates: Buy | $50 | $34.77 | +43.80% | 2 | May 6, 2025 | |
| DHR Danaher | Reiterates: Buy | $250 | $188.07 | +32.93% | 1 | Apr 23, 2025 | |
| CYRX Cryoport | Reiterates: Buy | $10 | $6.71 | +49.03% | 1 | Apr 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $60 | $48.36 | +24.07% | 2 | Apr 11, 2025 | |
| MYGN Myriad Genetics | Downgrades: Neutral | n/a | $4.45 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $37 | $23.02 | +60.73% | 3 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $35.64 | - | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $56 | $45.64 | +22.70% | 5 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $200 | $140.63 | +42.22% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $34.35 | - | 1 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $3.44 | +74.42% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.73 | +725.31% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.54 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $114.80 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $16.72 | +49.57% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.45 | - | 1 | Dec 14, 2023 |
Caris Life Sciences
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $28.29
Upside: +13.11%
GeneDx Holdings
Jun 30, 2025
Maintains: Buy
Price Target: $88 → $115
Current: $78.35
Upside: +46.79%
Tempus AI
Jun 30, 2025
Maintains: Buy
Price Target: $65 → $75
Current: $58.01
Upside: +29.29%
Neogen
Jun 30, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $4.78
Upside: +109.21%
Illumina
May 9, 2025
Maintains: Buy
Price Target: $122 → $114
Current: $94.80
Upside: +20.26%
Twist Bioscience
May 6, 2025
Reiterates: Buy
Price Target: $50
Current: $34.77
Upside: +43.80%
Danaher
Apr 23, 2025
Reiterates: Buy
Price Target: $250
Current: $188.07
Upside: +32.93%
Cryoport
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $6.71
Upside: +49.03%
Exact Sciences
Apr 11, 2025
Reiterates: Buy
Price Target: $60
Current: $48.36
Upside: +24.07%
Myriad Genetics
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.45
Upside: -
Apr 9, 2025
Maintains: Buy
Price Target: $45 → $37
Current: $23.02
Upside: +60.73%
Feb 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $35.64
Upside: -
Feb 24, 2025
Reiterates: Buy
Price Target: $56
Current: $45.64
Upside: +22.70%
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $140.63
Upside: +42.22%
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $34.35
Upside: -
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $3.44
Upside: +74.42%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $0.73
Upside: +725.31%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $11.54
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $114.80
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $16.72
Upside: +49.57%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.45
Upside: -